 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

InMode: Buying Opportunity At Oversold Market Levels...

InMode: Buying Opportunity At Oversold Market Levels

InMode's Dual-Edged Saga: Bright Prospects, Sharp Challenges...

InMode's Dual-Edged Saga: Bright Prospects, Sharp Challenges

Banque Cantonale Vaudoise trimmed its position in shares of InMode Ltd. (NASDAQ:INMD  Free Report) by 50.2% during the second quarter, according to its most recent disclosure with the...

Banque Cantonale Vaudoise Has $52,000 Holdings in InMode Ltd. (NASDAQ:INMD)

This indicator may be signaling INMD's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

InMode (INMD, $22.09) entered Uptrend as Momentum indicator ascends above 0 level on Nov 17, 2023

This indicator may be signaling that INMD's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

InMode (INMD, $21.72) entered Downtrend as Momentum indicator drops below 0 level on Nov 16, 2023

Shares of InMode Ltd. (NASDAQ:INMD  Get Free Report) have earned a consensus rating of Hold from the six analysts that are covering the stock, MarketBeat Ratings reports. Four...

InMode Ltd. (NASDAQ:INMD) Receives Consensus Recommendation of "Hold" from Analysts

Nova Eye Medical (OTCMKTS:ELXMF  Get Free Report) and InMode (NASDAQ:INMD  Get Free Report) are both medical companies, but which is the better business? We will contrast the two...

Comparing Nova Eye Medical (OTCMKTS:ELXMF) & InMode (NASDAQ:INMD)

InMode (INMD, $19.99) entered Uptrend as Momentum indicator ascends above 0 level on Nov 08, 2023

InMode to Present at Upcoming Investor Conferences and Events InMode to Present at Upcoming Investor Conferences and Events PR Newswire YOKNEAM, Israel, Nov. 6, 2023 YOKNEAM, Israel, Nov. 6, 2023...

InMode to Present at Upcoming Investor Conferences and Events

UBS Group restated their neutral rating on shares of InMode (NASDAQ:INMD  Free Report) in a research report released on Friday, MarketBeat.com reports. The firm currently has a $24.00 price...

InMode (NASDAQ:INMD) Receives Neutral Rating from UBS Group

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.

Watchers	7,032
52-Wk Low	$18.57
52-Wk High	$48.25

Market Cap	$1.99B
Volume (M)	1.41M
52-Wk High	$48.25
52-Wk Low	$18.57

Period	Estimated	Reported	Surprise	Result
Q3'23	$0.64	$0.61	-4.71%	MISSED
Q2'23	$0.65	$0.72	10.63%	BEAT
Q1'23	$0.47	$0.52	11.12%	BEAT
Q4'22	$0.67	$0.78	17.04%	BEAT
Q3'22	$0.58	$0.66	12.82%	BEAT

INMD Inmode Ltd

About

Feed

News

Sentiment

Earnings

Fundamentals